Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Plos One
|
June 26, 2019
Ligand-guided homology modeling drives identification of novel histamine H3 receptor ligands
David Schaller, Stefanie Hagenow, Holger Stark, et al.
Bioorganic & Medicinal Chemistry
|
July 2, 2018
Design, synthesis, and biological evaluation of novel oxadiazole- and thiazole-based histamine H<sub>3</sub>R ligands
Mohammad A Khanfar, David Reiner, Stefanie Hagenow, et al.
European Journal of Medicinal Chemistry
|
February 26, 2018
Novel indanone derivatives as MAO B/H<sub>3</sub>R dual-targeting ligands for treatment of Parkinson's disease
Anna Affini, Stefanie Hagenow, Aleksandra Zivkovic, et al.
Bioorganic Chemistry
|
March 11, 2020
Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and Aβ<sub>1-42</sub> aggregation
Erika Plazas, Stefanie Hagenow, Monica Avila Murillo, et al.
Drug Design, Development and Therapy
|
February 27, 2020
Reversible Small Molecule Inhibitors of MAO A and MAO B with Anilide Motifs
Jens Hagenow, Stefanie Hagenow, Kathrin Grau, et al.
ACS Medicinal Chemistry Letters
|
June 20, 2017
Systematic Data Mining Reveals Synergistic H3R/MCHR1 Ligands
David Schaller, Stefanie Hagenow, Gina Alpert, et al.
Molecules (Basel, Switzerland)
|
December 16, 2020
Parameters for Irreversible Inactivation of Monoamine Oxidase
Rona R Ramsay, Livia Basile, Antonin Maniquet, et al.
European Journal of Medicinal Chemistry
|
November 1, 2019
Search for new multi-target compounds against Alzheimer's disease among histamine H<sub>3</sub> receptor ligands
Marek Bajda, Dorota Łażewska, Justyna Godyń, et al.
Journal of Medicinal Chemistry
|
June 9, 2021
Adenosine A<sub>2A</sub>R/A<sub>1</sub>R Antagonists Enabling Additional H<sub>3</sub>R Antagonism for the Treatment of Parkinson's Disease
Stefanie Hagenow, Anna Affini, Elsa Y Pioli, et al.
Bioorganic & Medicinal Chemistry
|
November 19, 2018
Optimization and preclinical evaluation of novel histamine H<sub>3</sub>receptor ligands: Acetyl and propionyl phenoxyalkyl piperazine derivatives
Katarzyna Szczepańska, Tadeusz Karcz, Magdalena Kotańska, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Plos One
|
June 26, 2019
Ligand-guided homology modeling drives identification of novel histamine H3 receptor ligands
David Schaller, Stefanie Hagenow, Holger Stark, et al.
Bioorganic & Medicinal Chemistry
|
July 2, 2018
Design, synthesis, and biological evaluation of novel oxadiazole- and thiazole-based histamine H<sub>3</sub>R ligands
Mohammad A Khanfar, David Reiner, Stefanie Hagenow, et al.
European Journal of Medicinal Chemistry
|
February 26, 2018
Novel indanone derivatives as MAO B/H<sub>3</sub>R dual-targeting ligands for treatment of Parkinson's disease
Anna Affini, Stefanie Hagenow, Aleksandra Zivkovic, et al.
Bioorganic Chemistry
|
March 11, 2020
Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and Aβ<sub>1-42</sub> aggregation
Erika Plazas, Stefanie Hagenow, Monica Avila Murillo, et al.
Drug Design, Development and Therapy
|
February 27, 2020
Reversible Small Molecule Inhibitors of MAO A and MAO B with Anilide Motifs
Jens Hagenow, Stefanie Hagenow, Kathrin Grau, et al.
ACS Medicinal Chemistry Letters
|
June 20, 2017
Systematic Data Mining Reveals Synergistic H3R/MCHR1 Ligands
David Schaller, Stefanie Hagenow, Gina Alpert, et al.
Molecules (Basel, Switzerland)
|
December 16, 2020
Parameters for Irreversible Inactivation of Monoamine Oxidase
Rona R Ramsay, Livia Basile, Antonin Maniquet, et al.
European Journal of Medicinal Chemistry
|
November 1, 2019
Search for new multi-target compounds against Alzheimer's disease among histamine H<sub>3</sub> receptor ligands
Marek Bajda, Dorota Łażewska, Justyna Godyń, et al.
Journal of Medicinal Chemistry
|
June 9, 2021
Adenosine A<sub>2A</sub>R/A<sub>1</sub>R Antagonists Enabling Additional H<sub>3</sub>R Antagonism for the Treatment of Parkinson's Disease
Stefanie Hagenow, Anna Affini, Elsa Y Pioli, et al.
Bioorganic & Medicinal Chemistry
|
November 19, 2018
Optimization and preclinical evaluation of novel histamine H<sub>3</sub>receptor ligands: Acetyl and propionyl phenoxyalkyl piperazine derivatives
Katarzyna Szczepańska, Tadeusz Karcz, Magdalena Kotańska, et al.
Page
of 2